Skip to main content

Advertisement

SpringerLink
Log in

Concurrent development of psoriatic arthritis, drug-induced interstitial pneumonia, and increased anti-nuclear antibodies in a patient with psoriasis vulgaris undergoing adalimumab treatment

  • Correspondence
  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Veilleux MS, Shear NH. Biologics in patients with skin diseases. J Allergy Clin Immunol 2017; 139: 1423–30.

    Article  PubMed  Google Scholar 

  2. Kamata M, Tada Y. Safety of biologics in psoriasis. J Dermatol 2018; 45:279–86.

    Article  PubMed  Google Scholar 

  3. Toussirot É, Aubin F. Paradoxical reactions under TNF-α blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview. RMD Open 2016; 2: e000239.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Takahashi T, Asano Y, Shibata S, et al. Arthritis possibly induced and exacerbated by a tumour necrosis factor antagonist in a patient with psoriasis vulgaris. Br J Dermatol 2015; 172: 1458–60.

    Article  CAS  PubMed  Google Scholar 

  5. Haraoui B, Keystone E. Musculoskeletal manifestations and autoimmune diseases related to new biologic agents. Curr Opin Rheumatol 2006; 18:96–100.

    PubMed  Google Scholar 

  6. Atzeni F, Sarzi-Puttini P, Dell’Acqua D, et al. Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study. Arthritis Res Ther 2006; 8: R3.

    Article  CAS  PubMed  Google Scholar 

  7. Takase K, Horton SC, Ganesha A, et al. What is the utility of routine ANA testing in predicting development of biological DMARD-induced lupus and vasculitis in patients with rheumatoid arthritis? Data from a single-centre cohort. Ann Rheum Dis 2014; 73: 1695–9.

    Article  CAS  PubMed  Google Scholar 

  8. Perez-Alvarez R, Pérez-de-Lis M, Diaz-Lagares C, et al. Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases. Semin Arthritis Rheum 2011; 41: 256–64.

    Article  CAS  PubMed  Google Scholar 

  9. Kikuchi S, Umezawa Y, Hayashi M, et al. Interstitial pneumonia in two patients with psoriasis during ustekinumab treatment. J Dermatol 2016; 43:712–3.

    Article  PubMed  Google Scholar 

  10. Kajihara I, Yamada-Kanazawa S, Maeda-Otsuka S, Jinnin M, Akaike K, Ihn H. Secukinumab-induced interstitial pneumonia in a patient with psoriasis vulgaris. J Dermatol 2017; 44: e322–3.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan

    Masahito Yasuda, Naoko Morimoto & Osamu Ishikawa

  2. Orthopedic Surgery, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan

    Yukio Yonemoto

  3. Allergy and Respiratory Medicine, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan

    Noriaki Sunaga

Authors
  1. Masahito Yasuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Naoko Morimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yukio Yonemoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Noriaki Sunaga
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Osamu Ishikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masahito Yasuda.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yasuda, M., Morimoto, N., Yonemoto, Y. et al. Concurrent development of psoriatic arthritis, drug-induced interstitial pneumonia, and increased anti-nuclear antibodies in a patient with psoriasis vulgaris undergoing adalimumab treatment. Eur J Dermatol 29, 81–82 (2019). https://doi.org/10.1684/ejd.2018.3434

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2018.3434

Search

Navigation